ANI FDA Application, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Seeking Alpha
SummaryANIP submitted a prior approval supplement to the FDA.La Jolla's GIAPREZA to be used as COVID-19 treatment, stock shoots up.Aytu BioScience reported the launch of Regoxidine.ANI Pharmaceuticals Submit Application for Relaunching Cortrophin GelANI Pharmaceuticals Inc. (ANI Pharmaceuticals has spent over $100 million for re-establishing and validating the commercial corticotropin active pharmaceutical ingredient (API) and Cortrophin® Gel drug product manufacturing processes. The company had acquired the NDA for the gel from Merck (NYSE:MRKThe US corticotropin market currently has only one product H.P. Acthar® Gel from Mallinckrodt (NYSE:MNKsaidWe are very pleased to have submitted this PAS on schedule and in hopes of bringing Cortrophin® Gel back to the market for both patients and physicians."The company said that it has brought significant modernization to various processes.ANI also stated that it plans to market the drug at a substantial discount to the current pricing of H.P.
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- ANI Pharmaceuticals (ANIP) Is Up 7.0% After Raising 2026 Revenue Outlook and Expanding Rare Disease Team [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals (ANIP) Stock Trades Down, Here Is Why [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals: Strong 2025 Finish And Bullish 2026 Guidance [Seeking Alpha]Seeking Alpha
- Stocks making big moves yesterday: OneMain, Nextpower, ANI Pharmaceuticals, Akamai Technologies, and Lemonade [Yahoo! Finance]Yahoo! Finance
- Why ANI Pharmaceuticals (ANIP) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
ANIP
Earnings
- 11/7/25 - Beat
ANIP
Sec Filings
- 1/14/26 - Form 4
- 1/12/26 - Form 8-K
- 12/19/25 - Form 4
- ANIP's page on the SEC website